Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Design Therapeutics (DSGN) Net Margin (2020)

Design Therapeutics' Net Margin history spans 1 years, with the latest figure at 11700.0% for Q4 2020.

  • For Q4 2020, Net Margin changed N/A year-over-year to 11700.0%; the TTM value through Sep 2021 reached 86560.61%, changed N/A, while the annual FY2025 figure was 721.36%, 33381.0% down from the prior year.
  • Net Margin for Q4 2020 was 11700.0% at Design Therapeutics, up from 11915.0% in the prior quarter.
  • Across five years, Net Margin topped out at 438.73% in Q1 2020 and bottomed at 11915.0% in Q3 2020.